{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T12:45:52Z","timestamp":1776689152999,"version":"3.51.2"},"reference-count":26,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2000,3,1]],"date-time":"2000-03-01T00:00:00Z","timestamp":951868800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2000,3]]},"DOI":"10.1016\/s0168-3659(99)00243-6","type":"journal-article","created":{"date-parts":[[2002,7,25]],"date-time":"2002-07-25T21:36:57Z","timestamp":1027633017000},"page":"105-119","source":"Crossref","is-referenced-by-count":133,"title":["Polymer-bound camptothecin: initial biodistribution and antitumour activity studies"],"prefix":"10.1016","volume":"65","author":[{"given":"V.R","family":"Caiolfa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Zamai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A","family":"Fiorino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E","family":"Frigerio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C","family":"Pellizzoni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R","family":"d\u2019Argy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A","family":"Ghiglieri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.G","family":"Castelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Farao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E","family":"Pesenti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Gigli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F","family":"Angelucci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A","family":"Suarato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"16","key":"10.1016\/S0168-3659(99)00243-6_BIB1","first-page":"4385","article-title":"DNA topoisomerase I-mediated DNA cleavage and cytotoxicity of camptothecin","volume":"49","author":"Hsiang","year":"1989","journal-title":"Cancer Res."},{"key":"10.1016\/S0168-3659(99)00243-6_BIB2","doi-asserted-by":"crossref","first-page":"4629","DOI":"10.1021\/bi00437a018","article-title":"On the mechanism of topoisomerase I inhibition by camptothecin: evidence for binding to an enzyme\u2013DNA complex","volume":"28","author":"Hertzberg","year":"1989","journal-title":"Biochemistry"},{"key":"10.1016\/S0168-3659(99)00243-6_BIB3","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1021\/jm00105a017","article-title":"Synthesis of water-soluble (aminoalkyl)camptothecin analogues: inhibition of topoisomerase I and antitumour activity","volume":"34","author":"Kingsbury","year":"1990","journal-title":"J. Med. Chem."},{"key":"10.1016\/S0168-3659(99)00243-6_BIB4","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1126\/science.2555920","article-title":"DNA topoisomerase I-targeted chemotherapy of human colon cancer in xenografts","volume":"246","author":"Giovanella","year":"1989","journal-title":"Science"},{"key":"10.1016\/S0168-3659(99)00243-6_BIB5","first-page":"3052","article-title":"Complete growth inhibition of human cancer xenografts in nude mice by treatment with 20-(S)-camptothecin","volume":"51","author":"Giovanella","year":"1991","journal-title":"Cancer Res."},{"key":"10.1016\/S0168-3659(99)00243-6_BIB6","first-page":"25","article-title":"Toxicity of camptothecin (nsc-100880)","volume":"2","author":"Schaeppi","year":"1974","journal-title":"Cancer Chemother. Rep."},{"key":"10.1016\/S0168-3659(99)00243-6_BIB7","first-page":"125","article-title":"Pharmacologic studies of camptothecin (nsc-100880): distribution, plasma protein binding, and biliary excretion","volume":"57","author":"Guarino","year":"1973","journal-title":"Cancer Chemother. Rep."},{"key":"10.1016\/S0168-3659(99)00243-6_BIB8","first-page":"83","article-title":"Phase I clinical and pharmacokinetic study of PK1 (N-(2-hydroxypropyl)methacrylamide copolymer doxorubicin). First member of a new class of chemotherapeutic agents \u2014 drug\u2013polymer conjugates","volume":"5","author":"Vasey","year":"1999","journal-title":"Clin. Cancer Res."},{"issue":"3\u20134","key":"10.1016\/S0168-3659(99)00243-6_BIB9","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/0305-7372(87)90024-7","article-title":"Daunomycin- and adriamycin-N-(2-hydroxypropyl)methacrylamide copolymer conjugates; toxicity reduction by improved drug-delivery","volume":"14","author":"Seymour","year":"1987","journal-title":"Cancer Treat. Rev."},{"key":"10.1016\/S0168-3659(99)00243-6_BIB10","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/3540587888_14","article-title":"Polymer conjugates with anticancer activity","volume":"122","author":"Putnam","year":"1995","journal-title":"Adv. Polym. Sci."},{"key":"10.1016\/S0168-3659(99)00243-6_BIB11","first-page":"3980","article-title":"Combination chemotherapy and photodynamic therapy with N-(2-hydroxypropyl) methacrylamide copolymer-bound anticancer drugs inhibit human ovarian carcinoma heterotransplanted in nude mice","volume":"56","author":"Peterson","year":"1996","journal-title":"Cancer Res."},{"key":"10.1016\/S0168-3659(99)00243-6_BIB12","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/0014-3057(73)90063-3","article-title":"Poly(N-(2-hydroxypropyl)methacrylamide). I. Radical polymerization and copolymerization","volume":"9","author":"Kope\u010dek","year":"1973","journal-title":"Eur. Polym. J."},{"key":"10.1016\/S0168-3659(99)00243-6_BIB13","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1002\/macp.1977.021780804","article-title":"Reactive copolymers of N-(2-hydroxypropyl)methacrylamide with N-methacryloylated derivatives of l-leucine and l-phenylalanine, 1. Preparation, characterization, and reactions with diamines","volume":"178","author":"Kope\u010deck","year":"1977","journal-title":"Makromol. Chem."},{"key":"10.1016\/S0168-3659(99)00243-6_BIB14","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1002\/polc.5070660105","article-title":"Reactive copolymers of N-(2-hydroxypropyl) methacrylamide with N-methacryloylated derivatives of l-leucine and l-phenylalanine II. Reaction with the polymeric amine and stability of crosslinks towards chymotrypsin in vitro","volume":"66","author":"Kope\u010deck","year":"1979","journal-title":"J. Polym. Sci. Polym. Symp."},{"issue":"10","key":"10.1016\/S0168-3659(99)00243-6_BIB15","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1080\/10826079608005494","article-title":"Molecular characterization of polymeric antitumour drug carriers by size exclusion chromatography and universal calibration","volume":"19","author":"Mendichi","year":"1996","journal-title":"J. Liq. Chrom. Relat. Technol."},{"issue":"9","key":"10.1016\/S0168-3659(99)00243-6_BIB16","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1080\/10826079808005879","article-title":"Molar mass distribution of a polymer\u2013drug conjugate containing the antitumour drug paclitaxel by size exclusion chromatography and universal calibration","volume":"21","author":"Mendichi","year":"1998","journal-title":"J. Liq. Chrom. Relat. Technol."},{"key":"10.1016\/S0168-3659(99)00243-6_BIB17","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1006\/faat.1994.1030","article-title":"Quantitative whole body autoradiographic disposition of glycol heter in mice: effect of route of administration","volume":"22","author":"Ahmed","year":"1994","journal-title":"Fundam. Appl. Pharmacol."},{"key":"10.1016\/S0168-3659(99)00243-6_BIB18","doi-asserted-by":"crossref","first-page":"1997","DOI":"10.1002\/macp.1983.021841005","article-title":"Design of oligopeptide side-chains in poly[N-(2-hydroxypropyl)methacrylamide] copolymers to promote efficient degradation by lysosomal enzymes","volume":"184","author":"Duncan","year":"1983","journal-title":"Makromol. Chem."},{"key":"10.1016\/S0168-3659(99)00243-6_BIB19","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/0006-2952(96)00410-8","article-title":"Intracellularly biorecognizable derivatives of 5-fluorouracil","volume":"52","author":"Putnam","year":"1996","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/S0168-3659(99)00243-6_BIB20","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/0168-3659(95)00141-7","article-title":"Macromolecular prodrugs of 5-fluorouracil. 2: Enzymatic degradation","volume":"39","author":"Nichifor","year":"1996","journal-title":"J. Control. Release"},{"key":"10.1016\/S0168-3659(99)00243-6_BIB21","first-page":"3062","article-title":"Pharmacokinetics of the 9-amino and 10,11-methylenedioxy derivatives of camptothecin in mice","volume":"53","author":"Supko","year":"1993","journal-title":"Cancer Res."},{"key":"10.1016\/S0168-3659(99)00243-6_BIB22","unstructured":"M. Rowland, T.N. Tozer, Clinical Pharmacokinetics, Concepts and Applications, Williams and Wilkins (publ.), 3rd Edition, 1995."},{"key":"10.1016\/S0168-3659(99)00243-6_BIB23","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1007\/s002800050547","article-title":"Influence of route of administration on [3H]-camptothecin distribution and tumour uptake in CASE-bearing nude mice: whole-body autoradiographic studies","volume":"39","author":"Ahmed","year":"1996","journal-title":"Cancer Chemother. Pharmacol."},{"issue":"8","key":"10.1016\/S0168-3659(99)00243-6_BIB24","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1002\/(SICI)1099-1344(199608)38:8<733::AID-JLCR888>3.0.CO;2-6","article-title":"Stability of [3H]-labelled camptothecins","volume":"38","author":"Hintz","year":"1996","journal-title":"J. Label. Comp. Radiopharm."},{"issue":"6","key":"10.1016\/S0168-3659(99)00243-6_BIB25","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1016\/0006-2952(90)90293-T","article-title":"The pharmacokinetics of polymer-bound adriamycin","volume":"39","author":"Seymour","year":"1990","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/S0168-3659(99)00243-6_BIB26","first-page":"158","article-title":"Modulation of enhanced permeability in tumours by a bradykinin antagonist, a cycloxygenase inhibitor, and nitric oxide scavenger","volume":"231","author":"Wu","year":"1999","journal-title":"Cancer Res."}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365999002436?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365999002436?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,4,15]],"date-time":"2019-04-15T10:56:43Z","timestamp":1555325803000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365999002436"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,3]]},"references-count":26,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2000,3]]}},"alternative-id":["S0168365999002436"],"URL":"https:\/\/doi.org\/10.1016\/s0168-3659(99)00243-6","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2000,3]]}}}